Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$3.13 - $7.31 $1,220 - $2,850
390 Added 2.7%
14,859 $46,000
Q4 2022

Feb 07, 2023

BUY
$6.39 - $8.8 $13,776 - $18,972
2,156 Added 17.51%
14,469 $101,000
Q3 2022

Nov 07, 2022

BUY
$7.99 - $10.75 $6,280 - $8,449
786 Added 6.82%
12,313 $106,000
Q2 2022

Jul 28, 2022

BUY
$4.58 - $17.13 $52,793 - $197,457
11,527 New
11,527 $95,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.